Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Hum Reprod ; 12(11): 2388-92, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9436670

ABSTRACT

It is still unclear whether i.v. immunoglobulins (Ig) can facilitate the reproductive prognosis of women who have suffered recurrent pregnancy loss. We report the results of a multicentre placebo-controlled study on the effect of Ig administration on pregnancy outcome in 46 women who had suffered at least three recurrent miscarriages. All were screened to exclude chromosomal or Müllerian abnormalities, the presence of antinuclear antibodies, lupus anticoagulant (LA) or elevated titres of anticardiolipin antibodies which may have revealed an underlying autoimmune problem. To avoid a selection bias towards ongoing pregnancies, i.v. Ig or placebo were administered between weeks 5 and 7 of gestation for 2 consecutive days as soon as each woman knew she was pregnant and before embryonic heart activity could be detected. A further infusion was administered at week 8 when ultrasonography confirmed an ongoing embryonic development. In all, 68% of the women who received Ig went to term versus 79% of those who received a placebo (not significant), with no significant differences in the pregnancy course or the perinatal outcome. These results suggest either that women with recurrent miscarriages who have no recognized cause of pregnancy loss have a good reproductive prognosis without any treatment or that the emotional care associated with the administration of a placebo can indirectly facilitate the progression of pregnancy.


Subject(s)
Abortion, Habitual/drug therapy , Immunoglobulins, Intravenous , Adult , Double-Blind Method , Female , Humans , Italy , Pregnancy , Pregnancy Outcome
2.
J Am Assoc Gynecol Laparosc ; 3(4, Supplement): S50, 1996 Aug.
Article in English | MEDLINE | ID: mdl-9074250

ABSTRACT

During operative laparoscopy in the management of the ectopic pregnancy, conservative treatment consisting of linear salpingotomy and extraction of trophoblast must be carried out systematically. Until recently, tubal incision was performed with monopolar delivery systems. Bipolar electrosurgery has been used for many years, but is limited to coagulation. We applied bipolar technology in the conservative treatment of ectopic pregnancy. The instrument we used for the salpingotomy consisted of disposable Bilap needle or hook electrodes with shaft diameter of 5 mm and working length 33 cm. The trophoblast was extracted with a hydrodissection pump provided with 10- or 5-mm probes without irrigation holes. The electrodes were connected to an electrosurgical generator with maximum cutting power of 70 W. This system offers cutting in bipolar applications that are designed to eliminate current passing through tissues other than those selected. The conductive electrodes are closely spaced, reducing the energy requirements and power delivered to the surrounding tissue. The operative procedure was performed in 12 women. We had no persistent trophoblastic proliferation, and no patient required additional treatment.

3.
Obstet Gynecol ; 81(5 ( Pt 1)): 665-8, 1993 May.
Article in English | MEDLINE | ID: mdl-8469451

ABSTRACT

OBJECTIVE: To evaluate the correlation between natural killer cell activity and serum estradiol (E2) levels in patients with different stages of endometriosis. METHODS: Natural killer cell activity of peripheral blood lymphocytes and serum E2 levels were evaluated in 73 women who underwent laparoscopy for pelvic pain, infertility, and benign adnexal masses. RESULTS: The 33 patients (45%) with endometriosis showed a significant decrease in natural killer cell activity in relationship to an increase in disease stage (correlation coefficient r = -0.83, P < .001). A significant inverse relationship was observed between cytotoxicity and serum E2 levels (correlation coefficient r = -0.89, P < .001). CONCLUSION: The relationship between natural killer cell activity and serum E2 levels suggests that an immunoendocrine interaction plays an important role in the progression of endometriosis.


Subject(s)
Cytotoxicity, Immunologic/immunology , Endometriosis/immunology , Estradiol/blood , Killer Cells, Natural/immunology , Pelvic Neoplasms/immunology , Adult , Endometriosis/pathology , Endometriosis/physiopathology , Endometrium/pathology , Female , Humans , Neoplasm Staging , Pelvic Neoplasms/pathology , Pelvic Neoplasms/physiopathology
5.
Eur J Gynaecol Oncol ; 14(1): 51-5, 1993.
Article in English | MEDLINE | ID: mdl-8472733

ABSTRACT

From 1985 to 1991, 9 patients with endometrioid carcinoma of the ovary were treated and followed at the University of Ancona, Department of Gynecology and Obstetrics. Four patients (44.4%) had Stage I disease, 1 (11.1%) Stage II, 1 (11.1%) Stage III and 3 (33.3%) Stage IV. Six patients (66.6%) had grade 2 of the disease and 3 (33.3%) grade 3. Two of the patients (22.2%) had synchronous endometrial carcinoma while 3 had histologic evidence of endometriosis at the time of presentation. All the patients received treatment of combination of surgery, polychemotherapy, hormone and/or immunotherapy. The overall survival rate after a median follow up of 26.6 months was 66.6%. A high survival (100%) was observed for patients with associated endometriosis.


Subject(s)
Adenocarcinoma , Endometriosis , Ovarian Neoplasms , Adenocarcinoma/drug therapy , Adenocarcinoma/mortality , Adenocarcinoma/surgery , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carboplatin/administration & dosage , Cisplatin/therapeutic use , Combined Modality Therapy , Cyclophosphamide/administration & dosage , Endometriosis/drug therapy , Endometriosis/mortality , Endometriosis/surgery , Epirubicin/administration & dosage , Etoposide/administration & dosage , Female , Follow-Up Studies , Humans , Medroxyprogesterone/administration & dosage , Middle Aged , Neoplasm Staging , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/mortality , Ovarian Neoplasms/surgery , Retrospective Studies , Survival Rate , Tamoxifen/administration & dosage
6.
Gynecol Obstet Invest ; 35(2): 118-20, 1993.
Article in English | MEDLINE | ID: mdl-8383627

ABSTRACT

A longitudinal evaluation of the natural killer (NK) cell activity of peripheral blood lymphocytes was performed in 17 patients with advanced ovarian cancer (treated surgically and with subsequent multiagent chemotherapy) for a median follow-up period of 32 months. At the time of primary treatment, the mean value of NK cell activity was significantly lower in patients who then had disease progression (p < 0.05) than in patients with progression-free survival. During the follow-up period, no significant modifications of the NK cell activity were observed; only at the time of clinical disease progression did the NK cell activity show a significant reduction. We conclude that the NK cell activity is a potentially important prognostic factor.


Subject(s)
Adenocarcinoma, Mucinous/immunology , Cystadenoma/immunology , Killer Cells, Natural/immunology , Ovarian Neoplasms/immunology , Adenocarcinoma/drug therapy , Adenocarcinoma/immunology , Adenocarcinoma/surgery , Adenocarcinoma, Mucinous/drug therapy , Adenocarcinoma, Mucinous/surgery , Adult , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Chemotherapy, Adjuvant , Cisplatin/administration & dosage , Cyclophosphamide/administration & dosage , Cystadenoma/drug therapy , Cystadenoma/surgery , Cytotoxicity Tests, Immunologic , Cytotoxicity, Immunologic , Endometriosis/drug therapy , Endometriosis/immunology , Endometriosis/surgery , Epirubicin/administration & dosage , Female , Follow-Up Studies , Humans , Middle Aged , Neoplasm Recurrence, Local , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/surgery , Prognosis
7.
Ann Ostet Ginecol Med Perinat ; 113(2): 114-8, 1992.
Article in Italian | MEDLINE | ID: mdl-1299153

ABSTRACT

Neoplastic myometrial invasion is an important prognostic factor in local advanced endometrial carcinoma, conditioning therapeutic choice. In 34 patients with stage I and II endometrial carcinoma, the depth of myometrial invasion was evaluated by transvaginal sonography (TVS). In comparison with pathological findings, TVS showed an overall accuracy of 82.3% with a sensitivity of 82.6% and a specificity of 81.8%. The principal error was related to the underestimation of the lesion: negative predictive value of 49.2% vs positive predictive value of 90.4%. In conclusion, TVS is an accurate imaging method for staging of local advanced endometrial carcinoma.


Subject(s)
Myometrium/diagnostic imaging , Uterine Neoplasms/diagnostic imaging , Adult , Aged , Endometrial Neoplasms/pathology , Female , Humans , Middle Aged , Neoplasm Invasiveness/diagnostic imaging , Neoplasm Staging , Predictive Value of Tests , Ultrasonography/methods , Uterine Neoplasms/pathology
8.
Ann Ostet Ginecol Med Perinat ; 113(2): 119-23, 1992.
Article in Italian | MEDLINE | ID: mdl-1299154

ABSTRACT

Sixty-five couples with male infertility or unexplained infertility or infertility due to cervical factor underwent 156 cycles of homologue intrauterine insemination. The overall pregnancy rate was 16.5% with 2.4 mean value of insemination cycles for each couple. The highest pregnancy rate was observed in cases of cervical factor infertility. The mean age of patients who had pregnancy was 30 years (overall mean value 34 years) and the mean time of sterility was 3 years (overall mean value 4.4 years).


Subject(s)
Insemination, Artificial, Homologous/methods , Adult , Female , Humans , Infertility, Female , Infertility, Male , Insemination, Artificial, Homologous/statistics & numerical data , Male , Pregnancy , Treatment Outcome , Uterus
10.
Clin Exp Obstet Gynecol ; 19(4): 249-52, 1992.
Article in English | MEDLINE | ID: mdl-1294346

ABSTRACT

The "in vitro" cellular growth of 8 amniotic membranes from preterm deliveries with premature rupture of membrane (PROM) in absence of risk factors as cervical or vaginal infection (microbiologic negativity), cervical incontinence and other mechanical factors, was compared with cellular growth of 9 amnions from preterm deliveries without PROM. Amniotic membranes were set up in the Eagle basal medium with Earle salts and heat-inactivated fetal bovine serum (10%), gentamicin 50 micrograms/ml and amphotericin B 0.5 micrograms/ml. The results suggested that the growth potential of the cells (epithelial cells and fibroblasts) obtained from amnions with PROM was lower than that of cells obtained from amnions without PROM. We postulated that the premature rupture of membranes in patients without risk factors for PROM, would be conditioned by an intrinsic decrease of cellular growth potential.


Subject(s)
Amnion/pathology , Fetal Membranes, Premature Rupture/physiopathology , Obstetric Labor, Premature/physiopathology , Cell Division , Culture Techniques , Epithelium/pathology , Female , Fibroblasts/pathology , Humans , Pregnancy
12.
Ann Ostet Ginecol Med Perinat ; 113(1): 55-9, 1992.
Article in Italian | MEDLINE | ID: mdl-1476403

ABSTRACT

Although endometrial carcinoma is characterized by a precocious symptomatology, in 28.4-22.6% of cases at the time of diagnosis it is found to be at clinical stage higher than I. In the present study the diagnostic delay is related to the stage of disease. Our data suggest that diagnostic delay can cause a higher risk of advanced-stage disease; all the cases of stage III and IV disease, in fact, were diagnosed after more than 7 months. Diagnostic delay was also directly related to depth of myometrial invasion; the mean diagnostic delay was significantly shorter in patients with stage I disease and superficial myometrial invasion (3.92 vs 8.76 months) (p < 0.001). Therefore, diagnostic delay is directly related to well-established prognostic variables as well as to clinical stage and depth of myometrial invasion.


Subject(s)
Adenocarcinoma/diagnosis , Carcinoma, Squamous Cell/diagnosis , Endometrial Neoplasms/diagnosis , Adenocarcinoma/pathology , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/pathology , Endometrial Neoplasms/pathology , Endometrium/pathology , Female , Humans , Middle Aged , Prognosis , Time Factors
13.
Eur J Gynaecol Oncol ; 13(6): 514-21, 1992.
Article in English | MEDLINE | ID: mdl-1473533

ABSTRACT

The "in vitro" cell growth of 14 ovarian carcinomas was evaluated and related with the clinical-pathologic stage (FIGO) and grade of histologic differentiation of disease, with the patients' immunological pattern and with the relapse and survival rates. We identified 4 different patterns of "in vitro" cell growth (P1, P2, P3 and P4). Their correlation with the clinical-pathologic stages of disease as well as with the recurrence and survival rates was strong: 75% of recurrences in pattern P3 and 100% in pattern P4, while tumours with patterns P1 and P2 did not relapse. Similar results were obtained for survival, in fact 2 of the 3 patients who died from disease had cell growth pattern P4, and the other a P3. A significant correlation was found with basal natural killer cell activity of peripheral blood lymphocytes too: in patients with P1 neoplasia the basal NK cell activity was significantly higher (p < 0.05) while it was significantly lower (p < 0.05) in patients with P4 neoplasia in comparison with the others. We conclude that the "in vitro" biological behaviour of ovarian neoplasia can be regarded as prognostic factors even if patients' basal NK activity represents the most significant prognostic element, directly related to the recurrence rate (p = 0.002).


Subject(s)
Cystadenocarcinoma/pathology , Cystadenocarcinoma/therapy , Ovarian Neoplasms/pathology , Ovarian Neoplasms/therapy , Adolescent , Adult , Aged , Cystadenocarcinoma/immunology , Cystadenocarcinoma/mortality , Female , Humans , Immunity, Cellular , Killer Cells, Natural/immunology , Middle Aged , Neoplasm Recurrence, Local , Neoplasm Staging , Ovarian Neoplasms/immunology , Ovarian Neoplasms/mortality , Survival Rate , Tumor Cells, Cultured
14.
Gynecol Obstet Invest ; 34(2): 119-21, 1992.
Article in English | MEDLINE | ID: mdl-1398262

ABSTRACT

We have studied the systemic T-lymphocyte subset and, in particular, the natural-killer (NK) activity in 23 patients with cervical intra-epithelial neoplasia (CIN), and 11 controls (a history of normal cervical PAP smears and colposcopy patterns). The lymphocyte phenotypes were studied using a panel of monoclonal antibodies, and NK activity was evaluated as the percentage lysis of K 562 target cells. In patients with CIN we found a significant decrease in NK activity (p = 0.002) which was directly correlated with the grade of CIN, with no alterations in the absolute number of NK cells.


Subject(s)
Killer Cells, Natural/chemistry , Lymphocyte Subsets/chemistry , Uterine Cervical Neoplasms/blood , Adult , Colposcopy , Contraceptives, Oral , Evaluation Studies as Topic , Female , Humans , Immunophenotyping , Neoplasm Staging , Papanicolaou Test , Parity , Smoking/epidemiology , T-Lymphocyte Subsets/chemistry , Uterine Cervical Neoplasms/pathology , Vaginal Smears
15.
Eur J Gynaecol Oncol ; 13(2): 189-91, 1992.
Article in English | MEDLINE | ID: mdl-1316843

ABSTRACT

The outcome of HPV infection and its progression to neoplastic disease may be conditioned by the immune status of patients. In the present study we observed the systemic lymphocyte subset, with particular regard to NK cells and NK activity in 7 patients with HPV infection. The lymphocyte phenotypes in peripheral blood were studied using a panel of monoclonal antibodies, while NK activity was evaluated as percentage of lysis of K 562 target cells. We noticed a significant decrease of basal NK activity especially in patients with HPV 16-18 infection (p less than 0.001), without any difference in the absolute number of these cells.


Subject(s)
Lymphocyte Subsets , Papillomaviridae , Tumor Virus Infections/pathology , Adolescent , Adult , Antigens, Differentiation/analysis , Biopsy , Cytotoxicity Tests, Immunologic , Female , Humans , Tumor Virus Infections/immunology
16.
Eur J Gynaecol Oncol ; 13(3): 228-30, 1992.
Article in English | MEDLINE | ID: mdl-1618221

ABSTRACT

Malignant transformation arising in endometriosis has been reported in some cases. Following Sampson's criteria, about 0.7%-1% of all cases of endometriosis undergo malignant transformation and the ovary is the most frequent site. A case is reported of a patient with endometriosis which, after 10 years, grew into ovarian endometrioid carcinoma. The relationship between endometriosis and cancer suggests a radical treatment of endometriosis and a careful assessment of postmenopausal woman presenting reactivation signs.


Subject(s)
Adenocarcinoma/pathology , Endometriosis/pathology , Ovarian Neoplasms/pathology , Female , Humans , Middle Aged
17.
Gynecol Obstet Invest ; 34(1): 49-51, 1992.
Article in English | MEDLINE | ID: mdl-1526531

ABSTRACT

Basal natural killer (NK) cell activity in peripheral blood lymphocytes (PBLs) of 29 patients with gynecologic malignancy and 10 healthy controls was performed using K 562 cell line. A significant decrease of NK cell activity was observed in patients with gynecologic malignancy (p = 0.003). The NK cell activity of patients with poorly differentiated tumor or with stage IV of disease was significantly reduced with respect to patients at any other lower grade or earlier stage. We conclude that in patients with gynecologic malignancies there is a decrease of basal NK cell activity of PBLs, which is more significant in cases of distant tumor dissemination or poorly differentiated tumor (p less than 0.001).


Subject(s)
Genital Neoplasms, Female/immunology , Genital Neoplasms, Female/pathology , Killer Cells, Natural/immunology , Adult , Aged , Female , Humans , Lymphocyte Subsets , Male , Middle Aged , Neoplasm Staging
19.
Acta Eur Fertil ; 22(3): 157-8, 1991.
Article in English | MEDLINE | ID: mdl-1839482

ABSTRACT

Several Authors demonstrate changes in maternal immune system in women with pregnancy induced hypertension (PIH). In this study peripheral mononuclear cells were isolated in fifteen primigravid women with PIH and tested with monoclonal antibodies Leu 4, Leu 3, Leu 2 and Leu 7; in four women were studied monoclonal antibodies anti-Tac. The results were compared with a normotensive pregnant control group. T helper and T suppressor were increased but showed no statistical difference. The difference was statistically significant only for th NK cells. Tac antigen was expressed only on the Leu 3 induce subset. The PIH occurs because of a failure of maternal immune system.


Subject(s)
Hypertension/immunology , Pregnancy Complications, Cardiovascular/immunology , Antibodies, Monoclonal , Antigens, Differentiation/analysis , Female , Humans , Killer Cells, Natural , Leukocyte Count , Pregnancy , Pregnancy Trimester, Third , T-Lymphocytes, Helper-Inducer
20.
Acta Eur Fertil ; 21(5): 235-8, 1990.
Article in English | MEDLINE | ID: mdl-2132474

ABSTRACT

In this study we employed pulsatile GnRH therapy in different anovulatory disorders to test its real efficacy on ovulation induction. Ten adult women, 25-35 years old with primary or secondary infertility, underwent our study; all women showed anovulatory disorders such as Secondary Amenorrhea (n. 4), PCOD (n. 3) or Oligomenorrhea resistant to Clomiphene Citrate (n. 3). Pulsatile gonadotropin releasing hormone (GnRH) was given intravenously via automatic micropump, with a pulse interval of 90' and a pulse dose of 5 mcg/day. Ovulation was achieved in 7 cases (70%), whereas the failure of therapy was observed in 3 patients (30%), all affected by PCOD. The mean duration of follicular phase was 15 days and the ovulatory cycles did not need the luteal phase support. The maximum length of infusional therapy was 20 days with a low incidence of adverse side effects such as phlebitis; only in one patient a mild ovarian hyperstimulation was observed. Our results confirm that infusional pulsatile GnRH therapy is a very important tool to ovulation induction and it is more successful in primary or secondary amenorrhea and in hypothalamic disorders than in PCOD.


Subject(s)
Anovulation/drug therapy , Gonadotropin-Releasing Hormone/therapeutic use , Ovulation Induction , Adult , Amenorrhea/drug therapy , Clomiphene/therapeutic use , Drug Resistance , Female , Humans , Polycystic Ovary Syndrome/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...